Research progress of P2X7 receptor in inflammatory bowel disease

References

• Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158–165.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives. Wjg. 2014;20:11525–11537.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–727.
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.
   PubMed Web of Science ®Google Scholar
• Ke P, Shao BZ, Xu ZQ, et al. Intestinal autophagy and its pharmacological control in inflammatory bowel disease. Front Immunol. 2016;7:695.
   PubMed Web of Science ®Google Scholar
• Arseneau KO, Tamagawa H, Pizarro TT, et al. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep. 2007;9:508–512.
   PubMedGoogle Scholar
• Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol. 2007;102:2058–2069.
   PubMed Web of Science ®Google Scholar
• Graham DB, Becker CE, Doan A, et al. Functional genomics identifies negative regulatory nodes controlling phagocyte oxidative burst. Nat Commun. 2015;6:7838.
   PubMed Web of Science ®Google Scholar
• Li M, Wang B, Sun X, et al. Upregulation of intestinal barrier function in mice with DSS-induced colitis by a defined bacterial consortium is associated with expansion of IL-17A producing gamma delta T cells. Front Immunol. 2017;8:824.
   PubMed Web of Science ®Google Scholar
• Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296–307.
   PubMed Web of Science ®Google Scholar
• Kahlenberg JM, Dubyak GR. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K + release. Am J Physiol Cell Physiol. 2004;286:C1100–C1108.
   PubMed Web of Science ®Google Scholar
• Luna-Gomes T, Santana PT, Coutinho-Silva R. Silica-induced inflammasome activation in macrophages: role of ATP and P2X7 receptor. Immunobiology. 2015;220:1101–1106.
   PubMed Web of Science ®Google Scholar
• Ferrari D, Pizzirani C, Adinolfi E, et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol. 2006;176:3877–3883.
   PubMed Web of Science ®Google Scholar
• Deaglio S, Robson SC. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol. 2011;61:301–332.
   PubMedGoogle Scholar
• Seo J, Osorio JS, Schmitt E, et al. Hepatic purinergic signaling gene network expression and its relationship with inflammation and oxidative stress biomarkers in blood from peripartal dairy cattle. J Dairy Sci. 2014;97:861–873.
   PubMed Web of Science ®Google Scholar
• Wiley JS, Sluyter R, Gu BJ, et al. The human P2X7 receptor and its role in innate immunity. Tissue Antigens. 2011;78:321–332.
   PubMedGoogle Scholar
• Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol. 2004;240:31–304.
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol. 2002;22:364–373.
   PubMed Web of Science ®Google Scholar
• Zhang PA, Xu QY, Xue L, et al. Neonatal maternal deprivation enhances presynaptic P2X7 receptor transmission in insular cortex in an adult rat model of visceral hypersensitivity. CNS Neurosci Ther. 2017;23:145–154.
   PubMed Web of Science ®Google Scholar
• Gu BJ, Sluyter R, Skarratt KK, et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem. 2004;279:31287–31295.
   PubMed Web of Science ®Google Scholar
• Sánchez-Nogueiro J, Marín-García P, Miras-Portugal MT. Characterization of a functional P2X(7)-like receptor in cerebellar granule neurons from P2X(7) knockout mice. FEBS Lett. 2005;579:3783–3788.
   PubMed Web of Science ®Google Scholar
• Bartlett R, Stokes L, Sluyter R. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev. 2014;66:638–675.
   PubMed Web of Science ®Google Scholar
• Mehta N, Kaur M, Singh M, et al. Purinergic receptor P2X7: a novel target for anti-inflammatory therapy. Bioorg Med Chem. 2014;22:54–88.
   PubMed Web of Science ®Google Scholar
• Karmakar M, Katsnelson MA, Dubyak GR, et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat Commun. 2016;7:10555.
   PubMed Web of Science ®Google Scholar
• North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013–1067.
   PubMed Web of Science ®Google Scholar
• Surprenant A, Rassendren F, Kawashima E, et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996;272:735–738.
   PubMed Web of Science ®Google Scholar
• Ferrari D, Villalba M, Chiozzi P, et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol. 1996;156:15319.
   Web of Science ®Google Scholar
• Hechler B, Gachet C. Purinergic receptors in thrombosis and inflammation. Arterioscler Thromb Vasc Biol. 2015;35:2307–2315.
   PubMed Web of Science ®Google Scholar
• Kurashima Y, Amiya T, Nochi T, et al. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun. 2012;3. 1034.
   PubMed Web of Science ®Google Scholar
• Marques CC, Castelo-Branco MT, Pacheco RG, et al. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim Biophys Acta. 2014;1842:65–78.
   PubMed Web of Science ®Google Scholar
• Wan P, Liu X, Xiong Y, et al. Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling. Sci Rep. 2016;6:19108.
   PubMed Web of Science ®Google Scholar
• Na YA, Lee JY, Bang WJ, et al. Growth retardation of Escherichia coli by artificial increase of intracellular ATP. J Ind Microbiol Biotechnol. 2015;42:915–924.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the immune response to cell stress. Cell. 2006;126:659–662.
   PubMed Web of Science ®Google Scholar
• Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006;24:317–327.
   PubMed Web of Science ®Google Scholar
• VF D. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci. 2007;28:465–472.
   PubMed Web of Science ®Google Scholar
• Bernier LP. Purinergic regulation of inflammasome activation after central nervous system injury. J Gen Physiol. 2012;140:571.
   PubMed Web of Science ®Google Scholar
• Di VF, Vuerich M. Purinergic signaling in the immune system. Auton Neurosci. 2015;191:117–123.
   PubMed Web of Science ®Google Scholar
• Dubyak GR. P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 2012;14:1697–1706.
   PubMed Web of Science ®Google Scholar
• Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol. 2009;71:333–359.
   PubMed Web of Science ®Google Scholar
• Diezmos EF, Bertrand PP, Liu L. Purinergic signaling in gut inflammation: the role of connexins and pannexins. Front Neurosci. 2016;10:311.
   PubMed Web of Science ®Google Scholar
• Neves AR, Castelo-Branco MT, Figliuolo VR, et al. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Inflamm Bowel Dis. 2014;20:444–457.
   PubMed Web of Science ®Google Scholar
• Hofman P, Cherfils-Vicini J, Bazin M, et al. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer. Cancer Res. 2015;75:835–845.
   PubMed Web of Science ®Google Scholar
• Bottari NB, Pillat MM, MRC S, et al. Resveratrol-mediated reversal of changes in purinergic signaling and immune response induced by Toxoplasma gondii infection of neural progenitor cells. Purinergic Signal. 2019;15;77-84.
   Web of Science ®Google Scholar
• Friedman DJ, Künzli BM, A-Rahim YI, et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci USA. 2009;106:16788–16793.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Nishimura J, Shima T, et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808–812.
   PubMed Web of Science ®Google Scholar
• Longhi MS, Moss A, Jiang ZG, et al. Purinergic signaling during intestinal inflammation. J Mol Med. 2017;95:915–925.
   PubMed Web of Science ®Google Scholar
• Lammas DA, Stober C, Harvey CJ, et al. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity. 1997;7:433–444.
   PubMed Web of Science ®Google Scholar
• Fairbairn IP, Stober CB, Kumararatne DS, et al. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol. 2001;167:3300–3307.
   PubMed Web of Science ®Google Scholar
• Coutinho-Silva R, Stahl L, Raymond MN, et al. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity. 2003;19:403–412.
   PubMed Web of Science ®Google Scholar
• Coutinho-Silva R, Monteiro da Cruz C, Persechini PM, et al. The role of P2 receptors in controlling infections by intracellular pathogens. Purinergic Signal. 2007;3:83–90.
   PubMed Web of Science ®Google Scholar
• Souza CO, Santoro GF, Figliuolo VR, et al. Extracellular ATP induces cell death in human intestinal epithelial cells. Biochim Biophys Acta. 2012;1820:1867–1878.
   PubMed Web of Science ®Google Scholar
• Marsal J, Agace WW. Targeting T-cell migration in inflammatory bowel disease. J Intern Med. 2012;272:411–429.
   PubMed Web of Science ®Google Scholar
• Sturm A, de Souza HS, Fiocchi C. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. Curr Drug Targets. 2008;9:381–387.
   PubMed Web of Science ®Google Scholar
• Himmel ME, Hardenberg G, Piccirillo CA, et al. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008;125:145–153.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Caprioli F. T-cell-directed therapies in inflammatory bowel diseases. Clin Sci. 2010;118:707–715.
   PubMed Web of Science ®Google Scholar
• Rissiek B, Haag F, Boyer O, et al. P2X7 on mouse T cells: one channel, many functions. Front Immunol. 2015;6:204.
   PubMed Web of Science ®Google Scholar
• Cao B, Zhou X, Ma J, et al. Role of MiRNAs in inflammatory bowel disease. Dig Dis Sci. 2017;62:1426–1438.
   PubMed Web of Science ®Google Scholar
• Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1772–1788.
   PubMed Web of Science ®Google Scholar
• Figliuolo VR, Savio LEB, Safya H, et al. P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1183–1194.
   PubMed Web of Science ®Google Scholar
• Omenetti S, Pizarro TT. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol. 2015;6:639.
   PubMed Web of Science ®Google Scholar
• Purvis HA, Anderson AE, Young DA, et al. A negative feedback loop mediated by STAT3 limits human Th17 responses. J Immunol. 2014;193:1142–1150.
   PubMed Web of Science ®Google Scholar
• Schenk U, Frascoli M, Proietti M, et al. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal. 2011;4:ra12.
   PubMed Web of Science ®Google Scholar
• Cekic C, Linden J. Purinergic regulation of the immune system. Nat Rev Immunol. 2016;16:177–192.
   PubMed Web of Science ®Google Scholar
• Gicquel T, Victoni T, Fautrel A, et al. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages. Clin Exp Pharmacol Physiol. 2014;41:279–286.
   PubMed Web of Science ®Google Scholar
• Englezou PC, Rothwell SW, Ainscough JS, et al. P2X7R activation drives distinct IL-1 responses in dendritic cells compared to macrophages. Cytokine. 2015;74:293–304.
   PubMed Web of Science ®Google Scholar
• Gicquel T, Robert S, Loyer P, et al. IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages. Faseb J. 2015;29:4162–4173.
   PubMed Web of Science ®Google Scholar
• Fettelschoss A, Kistowska M, LeibundGut-Landmann S, et al. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression. Proc Natl Acad Sci USA. 2011;108:18055–18060.
   PubMed Web of Science ®Google Scholar
• Harris J, Hartman M, Roche C, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286:9587–9597.
   PubMed Web of Science ®Google Scholar
• Gicquel T, Le DB, Boichot E, et al. Purinergic receptors: new targets for the treatment of gout and fibrosis. Fundam Clin Pharmacol. 2017;31:136–146.
   PubMed Web of Science ®Google Scholar
• Coskun M. Intestinal epithelium in inflammatory bowel disease. Front Med. 2014;1:24.
   PubMedGoogle Scholar
• Martin CA, el-Sabban ME, Zhao L, et al. Adhesion and cytosolic dye transfer between macrophages and intestinal epithelial cells. Cell Adhes Commun. 1998;5:83–95.
   PubMed Web of Science ®Google Scholar
• Homaidan FR, Chakroun I, Dbaibo GS, et al. IL-1 activates two phospholipid signaling pathways in intestinal epithelial cells. Inflamm Res. 2001;50:375–381.
   PubMed Web of Science ®Google Scholar
• Martin CA, Homaidan FR, Palaia T, et al. Gap junctional communication between murine macrophages and intestinal epithelial cell lines. Cell Adhes Commun. 1998;5:437–449.
   PubMed Web of Science ®Google Scholar
• Hyun J, Romero L, Riveron R, et al. Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk. J Innate Immun. 2015;7:87–101.
   PubMed Web of Science ®Google Scholar
• Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39–48.
   PubMed Web of Science ®Google Scholar
• Bowdish DM, Davidson DJ, Lau YE, et al. Impact of LL-37 on anti-infective immunity. J Leukoc Biol. 2005;77:451–459.
   PubMed Web of Science ®Google Scholar
• Elssner A, Duncan M, Gavrilin M, et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol. 2004;172:4987–4994.
   PubMed Web of Science ®Google Scholar
• Feng YH, Wang L, Wang Q, et al. ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am J Physiol Cell Physiol. 2005;288:C1342–C1356.
   PubMed Web of Science ®Google Scholar
• Coutinho-Silva R, Stahl L, Cheung KK, et al. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1024–G1035.
   PubMed Web of Science ®Google Scholar
• Brannigan AE, OʼConnell RP, Hurley H, et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock. 2000;13:361–366.
   PubMed Web of Science ®Google Scholar
• Uddin M, Nong G, Ward J, et al. Prosurvival activity for airway neutrophils in severe asthma. Thorax. 2010;65:684–689.
   PubMed Web of Science ®Google Scholar
• Xue TC, Zhang L, Xie XY, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis. PLoS One. 2014;9:e96072.
   PubMed Web of Science ®Google Scholar
• Gökmen F, Akbal A, Reşorlu H, et al. Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal. 2015;29:294–298.
   PubMed Web of Science ®Google Scholar
• Sen BB, Rifaioglu EN, Ekiz O, et al. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol. 2014;33:223–227.
   PubMed Web of Science ®Google Scholar
• Okyay GU, Inal S, Oneç K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35:29–36.
   PubMed Web of Science ®Google Scholar
• Annabi B, Hiraiwa H, Mansfield BC, et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet. 1998;62:400–405.
   PubMed Web of Science ®Google Scholar
• Passalacqua S, Ferraro PM, Bresci G, et al. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. J Clin Apheresis. 2011;26:332–337.
   PubMed Web of Science ®Google Scholar
• Cesaro A, Brest P, Hofman V, et al. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am J Physiol Gastrointest Liver Physiol. 2010;299:G32–G42.
   PubMed Web of Science ®Google Scholar